Healthconn Corp (6665) Fair Value & Analysis
Healthcare · TW · Market cap 882M TWD
Fair value as of: Jun 24, 2026
Analysis
Healthconn Corp (6665) currently trades at 19.80 TWD, while our model-based Fair Value estimate is 7.20 TWD — implying the stock looks roughly 63.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Healthconn Corp. engages in the health services management in Taiwan and China. The company engages in the provision of health promotion consulting services, precision medicine health management services; genetic testing; and sales of molecular biology, genetics, microbial life science testing, precision instruments, and reagents. It also offers diagnostic solutions, including microbiology, total lab automation, molecular biology, life sciences, laboratory information systems, and environment and safety solutions; and warehouse and logistics solutions. Healthconn Corp. was founded in 2009 and is based in Taipei, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Healthconn Corp (6665) undervalued?
What is the fair value of 6665?
What is the quality score of 6665?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.